MENU

Can the AdvisorShares MSOS 2x Daily ETF (MSOX) Reach $5?

Category: #Trading
MSOX
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
Sep 11, 2026

Can the AdvisorShares MSOS 2x Daily ETF (MSOX) Reach $5?

Key Takeaways

  • The price target under discussion is $5 per share, a level that would require roughly a two-thirds advance from recent trading levels near $3.
  • The strongest bullish case rests on a sustained rally in U.S. cannabis equities, driven by the MSOX fund's 2x daily leveraged exposure to the AdvisorShares Pure US Cannabis ETF (MSOS).
  • The biggest obstacle is leverage itself: because the fund resets daily, prolonged volatility causes "decay" that can erode returns even when the underlying index is flat or slowly rising.
  • Key technical zones include support near the low-to-mid $2 range and resistance clustered around $4 to $4.20, with $5 acting as a psychological overhead supply area.
  • Investors should treat any $5 scenario as dependent on a forceful, sustained cannabis-sector breakout rather than a single sharp up day.

What Is MSOX?

The AdvisorShares MSOS 2x Daily ETF (MSOX) is a leveraged exchange-traded fund (ETF) that seeks to deliver two times (2x) the daily return of the AdvisorShares Pure US Cannabis ETF (MSOS). Unlike a conventional ETF that simply holds a basket of stocks, MSOX uses swap agreements to magnify the daily performance of its underlying fund, which invests primarily in U.S. multi-state operators (MSOs) — the large cannabis companies that operate across multiple states where marijuana is legal at the state level.

Because the 2x objective is calculated daily and then reset, MSOX is designed as a short-term trading instrument rather than a buy-and-hold position. The fund carries a net expense ratio of approximately 0.95% and holds assets in the range of roughly $60 million, making it a relatively small, specialized vehicle within the leveraged-ETF category.

Why Investors Are Watching the $5 Level

With MSOX recently changing hands around $3 after a 52-week range spanning roughly $1.66 to nearly $12, the $5 mark stands out as a meaningful round-number target that has appeared in retail and trader discussion as a level where prior holders may be "underwater." It represents a roughly 65–70% move from current prices — ambitious enough to be notable, yet not so distant as to be dismissed outright.

For a leveraged fund, however, a price objective is only meaningful when framed against the path of the underlying MSOS fund. To carry MSOX to $5, the underlying U.S. cannabis benchmark would likely need to mount a decisive, multi-week-to-multi-month advance, rather than choppy sideways movement.

What Could Drive the Next Leg Higher

The single most important catalyst for MSOX is regulatory progress at the federal level. U.S. cannabis operators have long been weighed down by their inability to deduct normal business expenses under Internal Revenue Code Section 280E and by limited access to banking and capital markets. Any meaningful movement on cannabis rescheduling, banking reform, or tax relief would directly improve the profitability of the MSOs that dominate the underlying MSOS portfolio, potentially sparking the kind of sustained rally that leveraged funds amplify.

Investor sentiment is a secondary but powerful force. Cannabis stocks are highly sensitive to headlines, and historical bouts of optimism have produced sharp, rapid repricing. A coordinated catalyst cycle — legislative progress combined with improving operator cash flows and short-covering — is the scenario most likely to propel MSOX toward higher targets.

The Leverage Problem: Volatility Decay

The greatest structural obstacle to a $5 MSOX is the mathematics of daily resetting. A 2x daily fund compounds its returns each session, which means that in volatile or range-bound markets the fund can lose value even when the underlying index is flat. If MSOS rises 10% one day and falls 10% the next, it ends roughly 1% lower; MSOX, at 2x daily exposure, ends considerably worse off.

This decay means MSOX needs not just gains, but a strong, mostly one-directional trend to reach a distant target. Over the past year, the fund's decline of well over 60% illustrates how damaging persistent drawdowns and volatility can be for a daily-reset leveraged product. Any investor evaluating a $5 price forecast must account for the possibility that even a meaningful underlying rally could be partially consumed by this compounding friction.

Technical Levels That Matter

From a technical-analysis standpoint, the path to $5 passes through several notable zones. Recent price action has shown support in the low-to-mid $2 area, while resistance has been identified near $4 to $4.20. A decisive break and hold above that $4-plus zone would be a meaningful first signal of renewed momentum, opening the door to the psychologically important $5 area, which also coincides with overhead supply from investors who bought at higher levels.

On the downside, failure to hold the $2.50–$2.60 zone would undermine the immediate bullish case and suggest the fund is still in a broader downtrend. The all-time high territory far above — once near $34 early in the fund's history — underscores how far the cannabis complex has fallen and how much sentiment would need to shift for a durable recovery.

AI Daily Buy/Sell Signals

Traders monitoring volatile, leveraged products like MSOX can use tools such as Tickeron's AI Daily Buy/Sell Signals to help filter market noise. This service uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Because leveraged ETFs can reverse quickly, having an automated, data-driven layer of monitoring can help traders spot opportunities, track existing positions, and identify shifting trends more efficiently than manual chart review alone.

Final Assessment

A move to $5 for the AdvisorShares MSOS 2x Daily ETF (MSOX) is possible but not probable in the absence of a major catalyst. The strongest factor in its favor is the potential for a regulatory-driven re-rating of U.S. cannabis operators, which would allow the fund's leverage to amplify a genuine sector breakout. Against that, daily-reset decay, the fund's small size, and the cannabis sector's long history of failed rallies all argue for caution.

For the $5 level to become realistic, investors would likely need to see sustained federal reform momentum, improving operator fundamentals, and a confirmed technical breakout above the $4 resistance zone. Until those conditions align, $5 should be viewed as an aspirational target rather than a base case. Investors should monitor regulatory headlines, cannabis-sector breadth, and MSOX's ability to hold its key support levels.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
MSOX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

MSOX and ETFs

Correlation & Price change

A.I.dvisor tells us that MSOX and SPXL have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MSOX and SPXL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MSOX
1D Price
Change %
MSOX100%
N/A
SPXL - MSOX
19%
Poorly correlated
+1.49%
SSO - MSOX
19%
Poorly correlated
+1.02%
QLD - MSOX
17%
Poorly correlated
+0.88%
TQQQ - MSOX
16%
Poorly correlated
+1.30%
TSLL - MSOX
15%
Poorly correlated
-3.02%
More